Masimo (MASI) Depreciation & Amortization (CF) (2009 - 2026)

Masimo's (MASI) quarterly Depreciation & Amortization (CF) came in at $8.1 million in Q2 2026, down 5.81% year-on-year from $8.6 million in Q2 2025, and down 40.44% quarter-over-quarter from $13.6 million in Q1 2026.

Masimo (MASI) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

Masimo's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $8.1 million for Q2 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 5.81% year-over-year to $8.1 million in Q2 2026; TTM through Apr 2026 was $38.3 million, a 18.68% decrease from a year earlier, with the FY2026 full-year figure at $38.8 million, down 20.0% from the prior year.
  • Depreciation & Amortization (CF) retreated to $8.1 million in Q2 2026 per MASI's latest filing, from $13.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $79.5 million in Q4 2022 and bottomed at -$36.9 million in Q4 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $10.4 million (2024), against an average of $15.8 million.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 705.68% in 2022; the steepest drop was 458.46% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $79.5 million in 2022, then tumbled by 146.42% to -$36.9 million in 2023, then jumped by 148.24% to $17.8 million in 2024, then slumped by 53.93% to $8.2 million in 2025, then slipped by 1.22% to $8.1 million in 2026.
  • Per Business Quant, the three latest MASI Depreciation & Amortization (CF) figures stand at $8.1 million (Q2 2026), $13.6 million (Q1 2026), and $8.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn 8.10 Mn

Historic Data

Download Data
DateValue
Apr 4, 2026 8.10 Mn
Apr 4, 2026 8.10 Mn
Jan 3, 2026 13.60 Mn
Jan 3, 2026 13.60 Mn
Sep 27, 2025 8.20 Mn
Sep 27, 2025 8.20 Mn
Jun 28, 2025 8.40 Mn
Jun 28, 2025 8.40 Mn
Mar 29, 2025 8.60 Mn
Mar 29, 2025 8.60 Mn
Dec 28, 2024 17.80 Mn
Dec 28, 2024 17.80 Mn
Sep 28, 2024 10.30 Mn
Sep 28, 2024 10.30 Mn
Jun 29, 2024 10.40 Mn
Jun 29, 2024 10.40 Mn
Mar 30, 2024 10.00 Mn
Mar 30, 2024 10.00 Mn
Dec 30, 2023 -36.90 Mn
Dec 30, 2023 -36.90 Mn